All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date Terminated | 2005-001501-26 | A randomized, double-blind pilot study vs placebo for the evaluation of the therapeutic effect of erythropoietin administered by iv route in patients whith diabetic neuropathy. | bad-data | |
Not reported | 2005-005873-31 | A randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of Erytropoietin administered by iv route as add-on treatment in patients affected by Amyotrophic Late... | 2008-05-08 | due-trials |
Not reported | 2005-005877-31 | Phase II study Systemic treatment with ZK219477 EPOTHILONE in recurrent Glioblastoma patients | 2008-03-05 | due-trials |
Not reported | 2006-000032-27 | MULTICENTRE RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF LONG-TERM ASCORBIC ACID TREATMENT IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A CMT-TRIAAL CMT-TRial Italian with Ascorbic Acid Long term | 2010-04-30 | due-trials |
Not reported | 2006-001039-23 | A Pilot Phase II Study for the evaluation of efficacy and tolerability of Gammaidroxybutyrate (ALCOVER) administered by oral route as add on treatmant in patients affected by DYT 11 Myoclonic Dystonia... | 2008-06-30 | due-trials |
Completed, but no date | 2006-001204-36 | Open pilot study for the evaluation of the analgesic effect of buprenorphine TDS administered as add-on treatment in patients with chronic neuropathic pain inadequately controlled by conventional ther... | bad-data | |
Ongoing | 2006-001858-27 | A randomized, double-blind pilot study vs placebo for the evaluation of efficacy and tolerability of doxycline administered by oral route in patients affected by Creutzfeldt-Jakob disease. | not-yet-due | |
Completed, but no date | 2007-001088-32 | A PHASE II RANDOMIZED, DOUBLE-BLIND STUDY VS. PLACEBO FOR THE EVALUATION OF EFFICACY AND TOLERABILITY OF SALBUTAMOL ADMINISTERED BY ORAL ROUTE IN PATIENTS AFFECTED BY SPINAL MUSCULAR ATHROPHY. | bad-data | |
Ongoing | 2007-001592-10 | A randomized, double-blind pilot study vs. placebo for the evaluation of efficacy and tolerability of tauroursodeoxycholic acid administered by oral route as add on treatment in patients affected by a... | not-yet-due | |
Ongoing | 2007-002817-37 | A PHASE II, PLACEBO CONTROLLED, DOSE FINDING PILOT STUDY OF PIXANTRONE EFFICACY ADMINISTERED INTRAVENOUSLY IN PATIENTS AFFECTED WITH MYASTHENIA GRAVIS | not-yet-due | |
Completed, but no date | 2007-003357-85 | Randomized placebo-controlled double-blind trial to assess safety and efficacy of erythropoietin in adult patients with Friedreich's ataxia (a pilot study) | bad-data | |
Completed, but no date | 2007-004359-12 | Simvastatin treatment in inclusion body myositis (IBM) | bad-data | |
Completed, but no date | 2008-000380-42 | Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis | bad-data | |
Completed, but no date Terminated | 2008-001645-26 | Phase II study: Systemic treatment with alternating weekly regimen of temozolomide and monthly fotemustine combination in recurrent glioblastoma patients. | bad-data | |
Not reported | 2008-003059-56 | Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pantothenate Kinase-Associated Neurodegeneration ICAND Trial | 2009-08-10 | due-trials |
Ongoing | 2008-003905-15 | Carmustine implant (Gliadel Wafer) plus adjuvant and concomitant Temozolomide in combination with radiotherapy in primary glioblastoma patients. | not-yet-due | |
Completed, but no date | 2009-013643-11 | Neuroprotective effects of palmitoylethanolamide in diabetic neuropathy: a pilot study. | bad-data | |
Ongoing | 2009-015614-21 | Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma | not-yet-due | |
Ongoing | 2009-016066-91 | SAFETY AND EFFICACY OF ERYTHROPOIETIN IN AMYOTROPHIC LATERAL SCLEROSIS: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL | not-yet-due | |
Ongoing | 2011-001329-26 | ErythroPOietin in ALS: a Study of dose-finding and Safety Eritropoietina nella SLA: uno studio di identificazione della dose e sicurezza | not-yet-due | |
Completed, but no date | 2011-002527-18 | Phase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas. Studio clinico di Fase II, in aperto, monocentrico, non contr... | bad-data | |
Ongoing | 2012-000869-21 | Pilot study: Imatinib for the treatment of plexiform neurofibromas in NF1 patients. Studio pilota sul trattamento con Imatinib di neurofibromi plessiformi in pazienti con neurofibromatosi di tipo ... | not-yet-due | |
Completed, but no date Terminated | 2013-004033-32 | AN OPEN, MONOCENTRIC, NOT CONTROLLED CLINICAL TRIAL TO DEVELOP AND EVALUATE THE CLINICAL APPLICATION OF A NEW BETA PROBE FOR RADIOGUIDED SURGERY IN MENINGIOMA TUMOR STUDIO ESPLORATIVO, MONOCENTRICO... | bad-data | |
Ongoing | 2014-002627-10 | A randomized, double-blind, controlled, monocenter, pivotal phase IIb study to evaluate the efficacy and safety of riluzole versus mexiletine in patients with non dystrophic myotonia mutated in SCN4A ... | not-yet-due | |
Ongoing | 2014-005367-32 | PROTEIN MISFOLDING, AMYOTROPHIC LATERAL SCLEROSIS AND GUANABENZ: A PHASE II RCT WITH FUTILITY DESIGN MISFOLDING PROTEICO, SCLEROSI LATERALE AMIOTROFICA E GUANABENZ: STUDIO CLINICO RANDOMIZZATO DI F... | not-yet-due | |
Completed, but no date Terminated | 2015-003127-62 | A Randomized, Placebo-Controlled, Pilot Crossover Study to Evaluate the Effect of Amifampridine Phosphate (3,4-Diaminopyridine Phosphate) in Patients with MuSK Antibody Positive Myasthenia Gravis A... | bad-data | |
Ongoing | 2016-000840-32 | Clinical and Urodynamic Evaluation of Bladder dysfunction in multiple sclerosis patients treated with Sativex Valutazione clinica e urodinamica della funzione vescicale in pazienti affetti da Scle... | not-yet-due | |
Ongoing | 2017-000559-26 | A multicentric randomized PRAGmatic trial to compare the effectiveness of fingolimod versus dimethyl-fumarate on patient overall disease experience in relapsing remitting Multiple Sclerosis: novel da... | not-yet-due | |
Not reported | 2018-001094-25 | Phenylbutyrate Therapy in Mitochondrial Disease with lactic acidosis: an opel label clinical trial in MELAS and PHD deficiency patients Phemi: Terapia con Fenilbutirrato nelle malattie mitocondrial... | 2022-01-21 | due-trials |
Not reported | 2019-001898-87 | Pilot study on sleep pathologies treatments in patients with Vegetative or Minimally conscious state diagnosis for improving Consciounsess level. STRIVE Project. Studio pilota sui trattamenti delle... | 2023-10-28 | due-trials |
Ongoing | 2021-003374-30 | A pilot study to Evaluate the Safety and Feasibility of Sonodynamic Therapy Using the ExAblate MRI-Guided Focused Ultrasound in the Treatment of Cerebral Glioblastomas. Studio Pilota per valutare l... | not-yet-due | |
Ongoing | 2021-004565-13 | Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease. A multicenter, randomized, double-blind, placebo-controlled, phase 2 trial. ... | not-yet-due |